Abstract：
OBJECTIVE: Prescribing by Endorsed Midwives has existed in Australia for more than ten years. Significant barriers exist in the bureaucracy surrounding prescribing and state and territory legislation which further constrain midwives capacity to prescribe required medications.
BACKGROUND: Current evidence indicates Endorsed Midwives improve timely access to medications and can experience both enablers and barriers to prescribing.
OBJECTIVE: To explore Endorsed Midwives\' lived experiences of medication prescribing, including which medications are being prescribed, how this affects the women in their care, midwives\' practice, and perspectives on the future of midwifery prescribing.
METHODS: A descriptive qualitative approach was used. Data collection occurred through semi-structured interviews (n=10) of Endorsed Midwives from varied Australian practice contexts and locations. Data analysis followed Reflexive Thematic Analysis.
RESULTS: Four themes were developed: Medication prescription as essential healthcare; Prescribing optimises midwifery practice; External structures can both promote and inhibit the capacity to prescribe; The future of prescribing.
CONCLUSIONS: Endorsed Midwife prescribing has the potential to positively impact women\'s maternity care and enable midwives to fulfil their scope of practice. However, limitations to prescribing need to be addressed to capitalise on these benefits.
CONCLUSIONS: Significant reform of health service policy, state and territory legislation and further development of the Pharmaceutical Benefits Scheme are required to fully embrace and capitalise on the full scope of Endorsed Midwives in the Australian Healthcare system.
BACKGROUND: Current evidence indicates Endorsed Midwives improve timely access to medications and can experience both enablers and barriers to prescribing.
OBJECTIVE: To explore Endorsed Midwives\' lived experiences of medication prescribing, including which medications are being prescribed, how this affects the women in their care, midwives\' practice, and perspectives on the future of midwifery prescribing.
METHODS: A descriptive qualitative approach was used. Data collection occurred through semi-structured interviews (n=10) of Endorsed Midwives from varied Australian practice contexts and locations. Data analysis followed Reflexive Thematic Analysis.
RESULTS: Four themes were developed: Medication prescription as essential healthcare; Prescribing optimises midwifery practice; External structures can both promote and inhibit the capacity to prescribe; The future of prescribing.
CONCLUSIONS: Endorsed Midwife prescribing has the potential to positively impact women\'s maternity care and enable midwives to fulfil their scope of practice. However, limitations to prescribing need to be addressed to capitalise on these benefits.
CONCLUSIONS: Significant reform of health service policy, state and territory legislation and further development of the Pharmaceutical Benefits Scheme are required to fully embrace and capitalise on the full scope of Endorsed Midwives in the Australian Healthcare system.
摘要：
目的：助产士的处方在澳大利亚已经存在了十多年。围绕处方和州和地区立法的官僚机构存在重大障碍，这进一步限制了助产士开出所需药物的能力。
背景：目前的证据表明，认可的助产士可以及时获得药物，并且可以经历处方的推动者和障碍。
目的：探索认可的助产士用药处方的生活经验，包括正在开的药物，这如何影响女性的护理，助产士\'练习，以及对助产处方未来的看法。
方法：采用描述性定性方法。数据收集是通过对来自不同澳大利亚实践背景和地点的认可助产士的半结构化访谈（n=10）进行的。数据分析遵循自反性主题分析。
结果：开发了四个主题：药物处方作为基本医疗保健；处方优化助产实践；外部结构可以促进和抑制处方能力；处方的未来。
结论：认可的助产士处方有可能对妇女的产妇护理产生积极影响，并使助产士能够履行其执业范围。然而,处方的局限性需要解决，以利用这些好处。
结论：卫生服务政策的重大改革，州和地区立法和药物福利计划的进一步发展需要充分接受和利用澳大利亚医疗保健系统中认可的助产士的全部范围。
背景：目前的证据表明，认可的助产士可以及时获得药物，并且可以经历处方的推动者和障碍。
目的：探索认可的助产士用药处方的生活经验，包括正在开的药物，这如何影响女性的护理，助产士\'练习，以及对助产处方未来的看法。
方法：采用描述性定性方法。数据收集是通过对来自不同澳大利亚实践背景和地点的认可助产士的半结构化访谈（n=10）进行的。数据分析遵循自反性主题分析。
结果：开发了四个主题：药物处方作为基本医疗保健；处方优化助产实践；外部结构可以促进和抑制处方能力；处方的未来。
结论：认可的助产士处方有可能对妇女的产妇护理产生积极影响，并使助产士能够履行其执业范围。然而,处方的局限性需要解决，以利用这些好处。
结论：卫生服务政策的重大改革，州和地区立法和药物福利计划的进一步发展需要充分接受和利用澳大利亚医疗保健系统中认可的助产士的全部范围。
